MapLight Therapeutics MPLT
NASDAQ MPLT
$9.63 -0.56 (-5.50%)
At close: Oct 1, 2026 · 4:00 PM EDT

MapLight Therapeutics (MPLT) Accumulated Depreciation (2024 - 2025)

Updated

MapLight Therapeutics (MPLT) reported Accumulated Depreciation of $2.64 million for Q4 2025, up 26.8% from $2.08 million a year earlier and up 5.6% from the prior quarter.

Analysis

MapLight Therapeutics (MPLT) Accumulated Depreciation (2024 - 2025) Analysis & Trends

  • By year, Accumulated Depreciation came in at $2.08 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 MapLight Therapeutics 463.00 Mn 463.00 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 2.64 Mn
Sep 30, 2025 2.50 Mn
Dec 31, 2024 2.08 Mn
API Access

MapLight Therapeutics Accumulated Depreciation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-depreciation&ticker=MPLT&period=max&api_key=YOUR_API_KEY